hrcak mascot   Srce   HID

Izvorni znanstveni članak

Comparison between famotidine (20 mg at bed time) and ranitidine (150 mg at bed time) in the prevention of duodenal ulcer relapse

Aleksandar Včev
Ivan Čandrlić
Dubravko Božić
Miroslav Volarić
Dubravko Paulini
Nikola Mićunović
Branimir Zelenka
Darko Horvat
Dubravka Tarle
Ivica Čandrlić, ml.
Boris Pospihalj
Andrijana Vegar

Puni tekst: engleski, pdf (2 MB) str. 7-11 preuzimanja: 455* citiraj
APA 6th Edition
Včev, A., Čandrlić, I., Božić, D., Volarić, M., Paulini, D., Mićunović, N., ... Vegar, A. (1991). Comparison between famotidine (20 mg at bed time) and ranitidine (150 mg at bed time) in the prevention of duodenal ulcer relapse. Medicinski vjesnik, 23 ((1-2)), 7-11. Preuzeto s https://hrcak.srce.hr/195571
MLA 8th Edition
Včev, Aleksandar, et al. "Comparison between famotidine (20 mg at bed time) and ranitidine (150 mg at bed time) in the prevention of duodenal ulcer relapse." Medicinski vjesnik, vol. 23, br. (1-2), 1991, str. 7-11. https://hrcak.srce.hr/195571. Citirano 25.06.2021.
Chicago 17th Edition
Včev, Aleksandar, Ivan Čandrlić, Dubravko Božić, Miroslav Volarić, Dubravko Paulini, Nikola Mićunović, Branimir Zelenka, et al. "Comparison between famotidine (20 mg at bed time) and ranitidine (150 mg at bed time) in the prevention of duodenal ulcer relapse." Medicinski vjesnik 23, br. (1-2) (1991): 7-11. https://hrcak.srce.hr/195571
Harvard
Včev, A., et al. (1991). 'Comparison between famotidine (20 mg at bed time) and ranitidine (150 mg at bed time) in the prevention of duodenal ulcer relapse', Medicinski vjesnik, 23((1-2)), str. 7-11. Preuzeto s: https://hrcak.srce.hr/195571 (Datum pristupa: 25.06.2021.)
Vancouver
Včev A, Čandrlić I, Božić D, Volarić M, Paulini D, Mićunović N i sur. Comparison between famotidine (20 mg at bed time) and ranitidine (150 mg at bed time) in the prevention of duodenal ulcer relapse. Medicinski vjesnik [Internet]. 1991 [pristupljeno 25.06.2021.];23((1-2)):7-11. Dostupno na: https://hrcak.srce.hr/195571
IEEE
A. Včev, et al., "Comparison between famotidine (20 mg at bed time) and ranitidine (150 mg at bed time) in the prevention of duodenal ulcer relapse", Medicinski vjesnik, vol.23, br. (1-2), str. 7-11, 1991. [Online]. Dostupno na: https://hrcak.srce.hr/195571. [Citirano: 25.06.2021.]
Puni tekst: hrvatski, pdf (2 MB) str. 7-11 preuzimanja: 58* citiraj
APA 6th Edition
Včev, A., Čandrlić, I., Božić, D., Volarić, M., Paulini, D., Mićunović, N., ... Vegar, A. (1991). Famotidin (ä 20 mg navečer) u usporedbi s ranitidinom (ä 150 mg navečer) u prevenciji recidiva dvanaesničnog vrijeđa. Medicinski vjesnik, 23 ((1-2)), 7-11. Preuzeto s https://hrcak.srce.hr/195571
MLA 8th Edition
Včev, Aleksandar, et al. "Famotidin (ä 20 mg navečer) u usporedbi s ranitidinom (ä 150 mg navečer) u prevenciji recidiva dvanaesničnog vrijeđa." Medicinski vjesnik, vol. 23, br. (1-2), 1991, str. 7-11. https://hrcak.srce.hr/195571. Citirano 25.06.2021.
Chicago 17th Edition
Včev, Aleksandar, Ivan Čandrlić, Dubravko Božić, Miroslav Volarić, Dubravko Paulini, Nikola Mićunović, Branimir Zelenka, et al. "Famotidin (ä 20 mg navečer) u usporedbi s ranitidinom (ä 150 mg navečer) u prevenciji recidiva dvanaesničnog vrijeđa." Medicinski vjesnik 23, br. (1-2) (1991): 7-11. https://hrcak.srce.hr/195571
Harvard
Včev, A., et al. (1991). 'Famotidin (ä 20 mg navečer) u usporedbi s ranitidinom (ä 150 mg navečer) u prevenciji recidiva dvanaesničnog vrijeđa', Medicinski vjesnik, 23((1-2)), str. 7-11. Preuzeto s: https://hrcak.srce.hr/195571 (Datum pristupa: 25.06.2021.)
Vancouver
Včev A, Čandrlić I, Božić D, Volarić M, Paulini D, Mićunović N i sur. Famotidin (ä 20 mg navečer) u usporedbi s ranitidinom (ä 150 mg navečer) u prevenciji recidiva dvanaesničnog vrijeđa. Medicinski vjesnik [Internet]. 1991 [pristupljeno 25.06.2021.];23((1-2)):7-11. Dostupno na: https://hrcak.srce.hr/195571
IEEE
A. Včev, et al., "Famotidin (ä 20 mg navečer) u usporedbi s ranitidinom (ä 150 mg navečer) u prevenciji recidiva dvanaesničnog vrijeđa", Medicinski vjesnik, vol.23, br. (1-2), str. 7-11, 1991. [Online]. Dostupno na: https://hrcak.srce.hr/195571. [Citirano: 25.06.2021.]

Sažetak
Famotidine given in a 20-mg dose at bed-time was compared to ranitidine administered in a dose of 150 mg at bed-time in the prevention of duodenal ulcer relapse during a six-month period. Seventy-one patients were included in the study. Patients were divided into two groups. Group 1 consisting 40 patients, after curing of acute illness, were treated with ranitidine, 150 mg at bed time, whereas group 2 consisting of 31 patients were treated with famotidine 20 mg at bed-time. Patients from both groups were additionally treated with antacide. After 3 months, one and no cases of relapse were recorded in groups 1 and 2, respectively. After 6 months, three cases of duodenal ulcer relapse were recorded in group 1 and two cases in group 2. Two out of three patients in group 1 and both patients in group 2 with duodenal ulcer relapse were smokers. There were no statistically significant differences between the two groups of patients in RBC, urea concentrations, creatinine and transaminases in blood after 3 and 6 months. No adverse side-effects were observed during the administration of either drug studied.

Ključne riječi
duodenal ulcer; famotidine; ranitidine

Hrčak ID: 195571

URI
https://hrcak.srce.hr/195571

[hrvatski]

Posjeta: 607 *